BioLife Solutions, Inc.
BLFS
$24.96
$0.1550.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 61.52% | 46.05% | -5.28% | 62.83% | 58.65% |
| Total Depreciation and Amortization | 36.76% | -50.12% | -47.36% | -79.04% | -75.26% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | -27.78% |
| Total Other Non-Cash Items | -44.82% | -38.72% | 3.77% | -67.77% | -64.43% |
| Change in Net Operating Assets | -113.17% | 120.45% | -6.92% | 108.18% | 118.70% |
| Cash from Operations | 167.46% | 230.85% | 92.20% | -335.32% | -47.24% |
| Capital Expenditure | 74.11% | 68.31% | 65.73% | 64.88% | 34.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 244.17% | -454.33% | 76.57% | 129.75% | 139.87% |
| Cash from Investing | 226.85% | -1,022.29% | 56.69% | 127.76% | 130.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,563.96% | -322.91% | 88.16% | 77.70% | 82.95% |
| Issuance of Common Stock | -98.95% | 4,986.34% | 7,005.44% | 5,368.59% | 3,172.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -140.13% | -305.38% | 24.96% | 77.75% | 82.96% |
| Cash from Financing | -164.04% | 5,615.20% | -48.06% | -35.98% | -35.09% |
| Foreign Exchange rate Adjustments | -100.00% | 47.83% | -162.37% | 22.67% | 116.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 275.50% | 162.75% | 123.63% | 126.25% | 131.68% |